A detailed history of Wellington Management Group LLP transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Wellington Management Group LLP holds 19,723 shares of AMPH stock, worth $771,958. This represents 0.0% of its overall portfolio holdings.

Number of Shares
19,723
Holding current value
$771,958
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$36.99 - $50.09 $729,553 - $987,925
19,723 New
19,723 $957,000
Q2 2022

Aug 15, 2022

BUY
$29.79 - $42.29 $473,661 - $672,411
15,900 New
15,900 $553,000

Others Institutions Holding AMPH

About Amphastar Pharmaceuticals, Inc.


  • Ticker AMPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,015,200
  • Market Cap $1.92B
  • Description
  • Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...
More about AMPH
Track This Portfolio

Track Wellington Management Group LLP Portfolio

Follow Wellington Management Group LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Management Group LLP with notifications on news.